Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder

The U.S. government declared the opioid epidemic as a national public health emergency in 2017, but regulatory frameworks that govern the treatment of opioid use disorder (OUD) through pharmaceutical interventions have remained inflexible. The emergence of the COVID-19 pandemic has effectively remov...

Descripción completa

Detalles Bibliográficos
Autores principales: Stringer, Kristi Lynn, Langdon, Kirsten J., McKenzie, Michelle, Brockmann, Brad, Marotta, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900610/
https://www.ncbi.nlm.nih.gov/pubmed/33612196
http://dx.doi.org/10.1016/j.jsat.2020.108263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900610/
https://www.ncbi.nlm.nih.gov/pubmed/33612196
http://dx.doi.org/10.1016/j.jsat.2020.108263

Ejemplares similares